FIELD: medicine.
SUBSTANCE: methods of the invention include administration of a therapeutically effective amount of erythorane or a pharmaceutically acceptable salt thereof to the infected patient.
EFFECT: application of the inventions allows to limit the duration of infection by reducing the titer of viruses, reducing the production of influenza-induced cytokines, reducing the level of liver enzymes and oxidized phospholipids.
34 cl, 13 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PROPHYLAXIS AND TREATMENT OF INFECTIOUS AND OTHER DISEASES BY USING COMPOUNDS BASED ON MONO- N DISACCHARIDES | 2001 |
|
RU2289410C2 |
| DEOXYNOYIRIMICIN DERIVATIVES AND METHODS FOR USE THEREOF | 2014 |
|
RU2702133C2 |
| METHODS AND COMPOSITIONS FOR INHIBITING POLYMERASE | 2011 |
|
RU2599013C2 |
| METHODS OF TREATING CORONAVIRUS INFECTIONS | 2021 |
|
RU2825648C1 |
| METHODS AND COMPOSITIONS FOR INHIBITING POLYMERASE | 2011 |
|
RU2718690C2 |
| MINUS-CHAIN-CONTAINING ATTENUATED VIRUSES WITH CHANGED ANTAGONISTIC ACTIVITY AS REGARDS FOR INTERFERON FOR APPLYING AS VACCINES AND PHARMACEUTICAL SUBSTANCES | 1999 |
|
RU2236252C2 |
| IL-8 INHIBITORS FOR USE IN TREATMENT AND/OR PREVENTION OF SECONDARY BACTERIAL INFECTIONS | 2018 |
|
RU2781280C2 |
| COMPOSITIONS AND METHODS BASED ON NEUTRALIZING ANTIBODIES DELIVERED INTRANASALLY FOR IMPROVED THERAPEUTIC EFFECTIVENESS | 2014 |
|
RU2701694C2 |
| COMPOSITIONS AND METHODS FOR TREATING IMMUNODEFICIENCY | 2015 |
|
RU2724058C2 |
| MODIFIED IMMUNOMODULATING PARTICLES | 2011 |
|
RU2587853C2 |
